When the U.S. Food and Drug Administration approved Cyberonic's Vagus Nerve Stimulation device for treatment-resistant depression, the agency asked the company to do a long-term study of the device's effectiveness once it went on the market. Now, in a new study, company researchers found that 32 percent to 42 percent of patients treated with the device showed a reduction in their depression symptoms after 50 weeks.
Read moreIt's said a gallant asthmatics can live a normal, active life. Yet what happens to the goofus asthmatic who doesn't treat his... Read more »
Question: Ledouix wrote... I have a few questions about the drug prozac. I would like to know long term side affects to a person who has... Read more »
Last week we all watched in horror as yet another school fell victim to a student with a gun. In the end, several students had died and... Read more »
Life can be better with the use of chemicals. Every year, I embark on chemical warfare in my rose garden. The bugs try to eat all of the... Read more »
For many older adults, the "golden years" are indeed golden. My parents, who are both over the age of 65, are enjoying their retirement... Read more »
People who experience psychological issues such as depression or substance abuse in childhood tend to have lower pay, fewer marriages, and less of... Read more »
An analysis of two studies has found that patients with bipolar disorder who receive long-term treatment with Seroquel and a mood stabilizer are... Read more »
“Treatment for depression should at least be on a par with that for other chronic diseases.” 2 An article in this week’s edition of The... Read more »
According to the National Institutes of Health, domestic violence is the most common cause of injury to women ages 15 to 44, and new research... Read more »
New research has found that people who are off work because of an injury are more prone to suffer high rates of depression and suicide. The study... Read more »